Results 21 to 30 of about 3,737 (192)
List and features of BEI resources M. tuberculosis hybridomas in this study.
, 2021 List and features of BEI resources M. tuberculosis hybridomas in this study.
Hui-Chen Chang Foreman (10925057) +2 more
core +1 more source
A glomerular permeability factor produced by human T cell hybridomas [PDF]
, 1991 A glomerular permeability factor produced by human T cell hybridomas. T cell hybridomas derived from the T cells of a patient with minimal change nephrotic syndrome (MCNS) made a glomerular permeability factor (GPF).
Igarashi, Masaya +4 more
core +1 more source
Immunogenomic engineering of a plug-and-(dis)play hybridoma platform
Nature Communications, 2016 Hybridomas are widely used for antibody screening and production due to their genetic stability and rapid proliferation. Here the authors demonstrate the rapid reprogramming of antibody specificity in hybridomas using CRISPR-Cas9.
Mark Pogson +4 more
doaj +1 more source
Is cancer progression caused by gradual or simultaneous acquisitions of new chromosomes?
Molecular Cytogenetics, 2018 Background Foulds defined, “Tumor progression (as a) permanent, irreversible qualitative change in one or more of its characters” (Cancer Res. 1954).
Mathew Bloomfield, Peter Duesberg
doaj +1 more source
A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain.
PLoS ONE, 2021 The identification of antibody variable regions in the heavy (VH) and light (VL) chains from hybridomas is necessary for the production of recombinant, sequence-defined monoclonal antibodies (mAbs) and antibody derivatives.
Ghasidit Pornnoppadol +6 more
doaj +1 more source
Journal of Immunology Research, 2016 The current study was to prepare a mouse-derived antibody against the angiotensin II type 1 receptor (AT1-mAb) based on monoclonal antibody technology, to provide a foundation for research on AT1-AA-positive diseases.
Mingming Wei +5 more
doaj +1 more source
A New Workflow to Generate Monoclonal Antibodies against Microorganisms
Applied Sciences, 2021 Monoclonal antibodies are used worldwide as highly potent and efficient detection reagents for research and diagnostic applications. Nevertheless, the specific targeting of complex antigens such as whole microorganisms remains a challenge.
Markus Göthel +5 more
doaj +1 more source
Проблемы особо опасных инфекций, 2014 Objective of the research was to use immunoblotting for studies of epitope targeting in monoclonal antibodies to 200 kDa Burkholderia pseudomallei antigen, which are synthesized by hybridomas-producers from the two collections in the laboratory of ...
I. I. Korsakova +5 more
doaj +1 more source
Hybridoma technology; advancements, clinical significance, and future aspects
Journal of Genetic Engineering and Biotechnology, 2021 Background Hybridoma technology is one of the most common methods used to produce monoclonal antibodies. In this process, antibody-producing B lymphocytes are isolated from mice after immunizing the mice with specific antigen and are fused with immortal ...
Sanchita Mitra, Pushpa Chaudhary Tomar
doaj +1 more source
Iranian Journal of Parasitology, 2022 Background: Leishmaniasis is a zoonotic disease, which is one of the serious public health problems in the world. Nowadays, antibody production using hybridoma technology may be a correct approach in terms of sensitivity in the diagnosis of diseases ...
Asli Pinar Zorba Yildiz +6 more
doaj +1 more source